OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
434
Results
Show all
Save search
Copy query
Show results for
Unknown
(434)
Publication Date
Release Date
2025
(58)
2020
(47)
2023
(39)
2021
(39)
2024
(37)
2022
(34)
2016
(24)
2015
(24)
2019
(21)
2014
(21)
2013
(18)
2012
(17)
2018
(14)
2017
(12)
2026
(9)
2011
(6)
2010
(6)
2009
(5)
2008
(2)
2007
(1)
Previous
page
1 / 44
You're on page
1
page
2
page
3
page
4
page
5
page
...
page
44
Next
page
Sort
by:
Relevance
Page size
10
Teclistamab Dosing in Responders: Modeling and Simulation Results from the MajesTEC-1 Study in Relapsed/Refractory Multiple Myeloma.
Not available
S-EPMC12307566
|
biostudies-literature
Cite
Healthcare resource use and costs related to surgical infections of tibial fractures in a Spanish cohort.
Not available
S-EPMC9651570
|
biostudies-literature
Cite
Using survey data to estimate the impact of the omicron variant on vaccine efficacy against COVID-19 infection.
Not available
S-EPMC9844193
|
biostudies-literature
Cite
Ustekinumab Intravenous Reinduction after Secondary Loss of Response in Patients with Crohn's Disease.
Not available
S-EPMC12688074
|
biostudies-literature
Cite
Talquetamab improves patient-reported symptoms and health-related quality of life in relapsed or refractory multiple myeloma: Results from the phase 1/2 MonumenTAL-1 study.
Not available
S-EPMC12239699
|
biostudies-literature
Cite
Characterization and Management of Cytokine Release Syndrome From the MonumenTAL-1 Study of Talquetamab in Patients With Relapsed/Refractory Multiple Myeloma.
Not available
S-EPMC12489744
|
biostudies-literature
Cite
Comparative Efficacy of Ciltacabtagene Autoleucel Versus Standard-of-Care Treatments for Patients with Previously Treated Relapsed or Refractory Multiple Myeloma: A Matching-Adjusted Indirect Comparison.
Not available
S-EPMC12182486
|
biostudies-literature
Cite
European Expert Panel Consensus on Outpatient Administration of Teclistamab and Talquetamab in Patients With Multiple Myeloma: Feasibility, Key Considerations, and Future Directions.
Not available
S-EPMC12402850
|
biostudies-literature
Cite
Comparative Efficacy of Talquetamab vs. Real-World Physician's Choice of Treatment in Triple-Class-Exposed Relapsed/Refractory Multiple Myeloma: Updated Analyses of MonumenTAL-1 vs. LocoMMotion/MoMMent.
Not available
S-EPMC12858606
|
biostudies-literature
Cite
Impact of difficult-to-treat depression for patients and society: a real-world study.
Not available
S-EPMC12724535
|
biostudies-literature
Cite
Previous
page
1 / 44
You're on page
1
page
2
page
3
page
4
page
5
page
...
page
44
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets